Gondo Y, Nakamura K, Nakao K, Sasaoka T, Ito K, Kimura M, Katsuki M
Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Biochem Biophys Res Commun. 1994 Jul 29;202(2):830-7. doi: 10.1006/bbrc.1994.2005.
Two steps of gene targeting were used to replace the p53 gene with the E. coli beta-galactosidase (lacZ) gene in mouse embryonic stem (ES) cells. The first targeting vector consisted of neo and herpes simplex virus thymidine kinase (HSV-tk) genes as a neo-tk cassette in the middle of the targeting vector. At the first targeting, the homologous recombinants became G418 resistant and ganciclovir (GANC) sensitive and were selected by G418 alone. At the second targeting, homologous recombination reciprocally exchanged the neo-tk casette in the ES cell chromosome with the lacZ fragment in the second targeting vector and thus made the ES cells GANC resistant. We obtained two ES cell clones, in which the p53 gene for both had been replaced with a totally non-homologous sequence of the lacZ gene. The germ-line transmission of the manipulated ES cells also demonstrated that the entire procedure had no detrimental effects on ES cells at all.
在小鼠胚胎干细胞(ES细胞)中,采用两步基因打靶法,用大肠杆菌β-半乳糖苷酶(lacZ)基因取代p53基因。第一个打靶载体由新霉素(neo)基因和单纯疱疹病毒胸苷激酶(HSV-tk)基因组成,作为neo-tk盒位于打靶载体中间。在第一次打靶时,同源重组体对G418耐药而对更昔洛韦(GANC)敏感,仅用G418进行筛选。在第二次打靶时,同源重组将ES细胞染色体中的neo-tk盒与第二个打靶载体中的lacZ片段进行相互交换,从而使ES细胞对GANC耐药。我们获得了两个ES细胞克隆,二者的p53基因均已被lacZ基因的完全非同源序列所取代。对经过操作的ES细胞进行种系传递研究还表明,整个过程对ES细胞完全没有有害影响。